In a late-stage clinical trial, Merck’s new experimental pill enlicitide was able to reduce LDL cholesterol levels by up to 60%, results similar to those obtained with injectable medications, in today’s bite-sized hospital and health industry news from Maryland, New Jersey, and New York. Maryland: FDA has approved a new drug developed by Kura Oncology […]
